View drug registration information details.
Items | Registration information |
ID | 460 |
No | 460 |
Brand Name | SOVEL TABLET |
Ingredients | SOFOSBUVIR 400 MG, VELPATASVIR 100 MG |
Dosage Form | TABLET |
Primary Packaging | ALU-ALU BLISTER |
Storage | STORE BELOW 30 C |
Shelf Life | 02 YEARS |
Pack Size | BOX OF 4 X 7'S |
Dispensing Category | PRESCRIPTION ONLY |
ATC Classification | J05AP |
Pharmaceutical Class | ANTIVIRAL |
Indications | FOR THE TREATMENT OF CHRONIC HEPATITIS C VIRUS INFECTION IN ADULT |
Contraindications | HYPERSENSITIVITY, QT INTERVAL PROLONGATION OR CONGENITAL LONG QT SYNDROME |
Side Effects | HEAD ACHE, FATIQUE, LOW BLOOD IRON. NAUSEA, INSOMNIA, |
Unit Price | |
EDL |
No |
Description | PEACH COLOR, BICONVEX, OVAL SHAPED, FILM COATED TABLET, ENGRAVED SEARLE ON ONE SIDE AND BREAKLINE ON OTHER SIDE |
Note | |
License Owner | POUN SAP PHARMA CO.,LTD |
Manufacturer | THE SEARLE CO.,LTD |
Country | PAKISTAN |
Import Registration No | 005961-EX |
Import Registration Date | 2016-12-20 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2024-05-09 |
FDD Registration No | 02 I 5891/25 |
FDD Registration Date | 24-ก.พ.-2025 |
Expiry Date | 23-ก.พ.-2030 |
Back to drug list
|